Consensus Becton, Dickinson and Company London S.E.

Stocks

0R19

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 09:30:01 2026-09-09 EDT			5-day change	1st Jan Change
177.15 ^USD	-1.59%		-6.55%	-9.45%

09-09	Becton, Dickinson and Company Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 through Sep-10-2026
09-01	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat	MT

19845f7f6dd5c9f1e5.Me4wnBjB3zihPSlbYcDj8o6jUeyg5veGDZFNeEdRI_0.f99dyWyKkVGXDxghDu2XpuT5CKvKs5bTSMk-NCM2ZKdBt2eqaaWRFZRiEQ~95edf6809c200665fa80fe74584aab40

Analysts' recommendations: Becton, Dickinson and Company

08-31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
08-13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
08-12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08-07	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08-07	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08-07	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08-07	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08-07	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
08-07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
08-05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
07-28	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-09	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
07-06	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
06-12	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
05-27	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
05-08	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
05-07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
05-07	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
05-04	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT
05-04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
04-17	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
04-14	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+14.23%
	MEDTRONIC PLC					+14.01%
	CENCORA, INC.					+14.22%
	HOYA CORPORATION					+31.84%
	BECTON, DICKINSON AND COMPANY					+8.82%
	DEXCOM, INC.					+12.21%
	MEDLINE INC.					+30.98%
	WEST PHARMACEUTICAL SERVICES, INC.					+20.31%
	TERUMO CORPORATION					+38.48%
	Average					+20.57%
	Weighted average by Cap.					+17.24%